Sponsor Pipeline

Astellas Pharma Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
1
Phase 3
6
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-01 NCT05382559
A Study of ASP3082 in Adults With Advanced Solid Tumors		 Trial sites expanded: 62 -> 66 locations
Active Trials by Phase
Phase 4
1
Phase 3
1
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06970665 A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With… Geographic Atrophy Active, Not Recruiting
Phase 3
NCT03182244 A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory… AML With FLT3 Mutation Active, Not Recruiting
Phase 1/2
NCT07318714 A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a… Chronic Ischemic Stroke Recruiting
Phase 1
NCT07094204 A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors Solid Tumor Recruiting
NCT05382559 A Study of ASP3082 in Adults With Advanced Solid Tumors Solid Tumor Recruiting
Disease Areas
Acute Myeloid Leukemia (AML) (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Colorectal Cancer (1) Pancreatic Cancer (1) Stroke (1)
Get alerts when Astellas Pharma Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free